[1] VOS T, ABAJOBIR AA, ABATE KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259.
[2] HUNTER DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182): 1745-1759.
[3] SAFIRI S, KOLAHI AA, SMITH E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819-828.
[4] KOLASINSKI SL, NEOGI T, HOCHBERG MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162.
[5] MUSUMECI G, AIELLO FC, SZYCHLINSKA MA, et al. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015;16(3):6093-6112.
[6] 向小娜,余曦,刘岩,等.富血小板血浆与脉冲电磁场联合应用治疗骨关节炎:理论与临床研究的进展[J].中国组织工程研究,2019, 23(30): 4868-4874.
[7] DOBSON GP, LETSON HL, GRANT A, et al. Defining the osteoarthritis patient: back to the future. Osteoarthritis Cartilage. 2018;26(8):1003-1007.
[8] MURPHY C, WITHROW J, HUNTER M, et al. Emerging role of extracellular vesicles in musculoskeletal diseases. Mol Aspects Med. 2018;60:123-128.
[9] LI J, PEI M. Cell senescence: a challenge in cartilage engineering and regeneration. Tissue Eng Part B Rev. 2012;18(4):270-287.
[10] LI Y, WU Y, JIANG K, et al. Mangiferin Prevents TBHP-Induced Apoptosis and ECM Degradation in Mouse Osteoarthritic Chondrocytes via Restoring Autophagy and Ameliorates Murine Osteoarthritis. Oxid Med Cell Longev. 2019;2019:8783197.
[11] GUILAK F, NIMS RJ, DICKS A, et al. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71-72:40-50.
[12] TU J, HUANG W, ZHANG W, et al. TWIST1-MicroRNA-10a-MAP3K7 Axis Ameliorates Synovitis of Osteoarthritis in Fibroblast-like Synoviocytes. Mol Ther Nucleic Acids. 2020;22:1107-1120.
[13] RAHMATI M, NALESSO G, MOBASHERI A, et al. Aging and osteoarthritis: Central role of the extracellular matrix. Ageing Res Rev. 2017;40:20-30.
[14] HUNZIKER EB, QUINN TM, HÄUSELMANN HJ. Quantitative structural organization of normal adult human articular cartilage. Osteoarthritis Cartilage. 2002;10(7):564-572.
[15] GLYN-JONES S, PALMER AJ, AGRICOLA R, et al. Osteoarthritis. Lancet. 2015;386(9991):376-387.
[16] DE VOS RJ, WEIR A, VAN SCHIE HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-149.
[17] FOSTER TE, PUSKAS BL, MANDELBAUM BR, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009; 37(11):2259-2272.
[18] DOHAN EHRENFEST DM, RASMUSSON L, ALBREKTSSON T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158-167.
[19] LOUIS ML, MAGALON J, JOUVE E, et al. Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared With Viscosupplementation. Arthroscopy. 2018;34(5):1530-1540.e2.
[20] KON E, BUDA R, FILARDO G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472-479.
[21] SAMPSON S, REED M, SILVERS H, et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2010;89(12):961-969.
[22] THÉRY C, WITWER KW, AIKAWA E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
[23] KALLURI R, LEBLEU VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
[24] CHENG N, DU D, WANG X, et al. Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes. Trends Biotechnol. 2019;37(11): 1236-1254.
[25] LI D, WANG Y, JIN X, et al. NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice. J Neuroinflammation. 2020;17(1):126.
[26] CHEW JRJ, CHUAH SJ, TEO KYW, et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration. Acta Biomater. 2019;89:252-264.
[27] MICHAEL JW, SCHLÜTER-BRUST KU, EYSEL P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107(9):152-162.
[28] ECKSTEIN F, LE GRAVERAND MP, CHARLES HC, et al. Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis. 2011;70(7):1223-1230.
[29] WILSON JF. To stop osteoarthritis, fixing cartilage may not be enough. Ann Intern Med. 2007;147(6):437-439.
[30] ANDRIACCHI TP. Osteoarthritis: Probing knee OA as a system responding to a stimulus. Nat Rev Rheumatol. 2012;8(7):371-372.
[31] BURR DB, GALLANT MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665-673.
[32] ASO K, SHAHTAHERI SM, HILL R, et al. Associations of Symptomatic Knee Osteoarthritis With Histopathologic Features in Subchondral Bone. Arthritis Rheumatol. 2019;71(6):916-924.
[33] YUAN C, PAN Z, ZHAO K, et al. Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas. Bone Res. 2020;8(1):38.
[34] DOYLE LM, WANG MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 2019;8(7):727.
[35] CAO Q, GUO Z, YAN Y, et al. Exosomal long noncoding RNAs in aging and age-related diseases. IUBMB Life. 2019;71(12):1846-1856.
[36] WHITESIDE TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018;35:69-79.
[37] LIU Y, LIN L, ZOU R, et al. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle. 2018;17(21-22):2411-2422.
[38] HA DH, KIM HK, LEE J, et al. Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration. Cells. 2020;9(5):1157.
[39] LIU J, REN L, LI S, et al. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 2021;11(9):2783-2797.
[40] DOHAN EHRENFEST DM, RASMUSSON L, ALBREKTSSON T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009; 27(3):158-167.
[41] IYER SR, SCHEIBER AL, YAROWSKY P, et al. Exosomes Isolated From Platelet-Rich Plasma and Mesenchymal Stem Cells Promote Recovery of Function After Muscle Injury. Am J Sports Med. 2020;48(9):2277-2286.
[42] ZHANG W, DONG X, WANG T, et al. Exosomes derived from platelet-rich plasma mediate hyperglycemia-induced retinal endothelial injury via targeting the TLR4 signaling pathway. Exp Eye Res. 2019;189:107813.
[43] CERVENAKOVA L, SAÁ P, YAKOVLEVA O, et al. Are prions transported by plasma exosomes? Transfus Apher Sci. 2016;55(1):70-83.
[44] GUO SC, TAO SC, YIN WJ, et al. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017;7(1):81-96.
[45] TORREGGIANI E, PERUT F, RONCUZZI L, et al. Exosomes: novel effectors of human platelet lysate activity. Eur Cell Mater. 2014;28:137-151.
[46] SAÁ P, YAKOVLEVA O, DE CASTRO J, et al. First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification. J Biol Chem. 2014;289(42):29247-29260.
[47] YIN W, QI X, ZHANG Y, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects. J Transl Med. 2016;14:73.
[48] LIU X, WANG L, MA C, et al. Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/β-catenin signaling pathway. J Orthop Surg Res. 2019;14(1):470.
[49] NILFOROUSHZADEH MA, AGHDAMI N, TAGHIABADI E. Effects of Adipose-Derived Stem Cells and Platelet-Rich Plasma Exosomes on The Inductivity of Hair Dermal Papilla Cells. Cell J. 2021;23(5):576-583.
[50] XU Y, LIN Z, HE L, et al. Platelet-Rich Plasma-Derived Exosomal USP15 Promotes Cutaneous Wound Healing via Deubiquitinating EIF4A1. Oxid Med Cell Longev. 2021;2021:9674809.
[51] ZHANG Y, WANG X, CHEN J, et al. Exosomes derived from platelet-rich plasma administration in site mediate cartilage protection in subtalar osteoarthritis. J Nanobiotechnology. 2022;20(1):56.
[52] ZHANG W, JIANG H, KONG Y. Exosomes derived from platelet-rich plasma activate YAP and promote the fibrogenic activity of Müller cells via the PI3K/Akt pathway. Exp Eye Res. 2020;193:107973.
[53] FLAMANT S, TAMARAT R. Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure. Radiat Res. 2016;186(2):203-218.
[54] TAO SC, YUAN T, RUI BY, et al. Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway. Theranostics. 2017;7(3):733-750.
[55] LEBLANC P, ARELLANO-ANAYA ZE, BERNARD E, et al. Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission. Methods Mol Biol. 2017;1545:153-176.
[56] XU X, LIANG Y, LI X, et al. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269:120539.
[57] MATHIEU M, NÉVO N, JOUVE M, et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun. 2021;12(1):4389.
[58] OTAHAL A, KRAMER K, KUTEN-PELLA O, et al. Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model. Int J Mol Sci. 2021;22(13):7224.
[59] RUI S, YUAN Y, DU C, et al. Comparison and Investigation of Exosomes Derived from Platelet-Rich Plasma Activated by Different Agonists. Cell Transplant. 2021;30:9636897211017833.
[60] SAUMELL-ESNAOLA M, DELGADO D, GARCÍA DEL CAÑO G, et al. Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization. Int J Mol Sci. 2022;23(5):2861.
[61] SHAO S, PAN R, CHEN Y. Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer. Trends Endocrinol Metab. 2020;31(12):885-890.
[62] ETULAIN J, MENA HA, MEISS RP, et al. An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018;8(1):1513.
[63] MELKI I, TESSANDIER N, ZUFFEREY A, et al. Platelet microvesicles in health and disease. Platelets. 2017;28(3):214-221.
[64] WU J, PIAO Y, LIU Q, et al. Platelet-rich plasma-derived extracellular vesicles: A superior alternative in regenerative medicine? Cell Prolif. 2021;54(12):e13123.
[65] XU J, XIE G, YANG W, et al. Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes. Cell Cycle. 2021;20(15):1487-1499. |